Regulatory Systems in Bone Marrow for Hematopoietic Stem/Progenitor Cells Mobilization and Homing

Regulation of hematopoietic stem cell release, migration, and homing from the bone marrow (BM) and of the mobilization pathway involves a complex interaction among adhesion molecules, cytokines, proteolytic enzymes, stromal cells, and hematopoietic cells. The identification of new mechanisms that regulate the trafficking of hematopoietic stem/progenitor cells (HSPCs) cells has important implications, not only for hematopoietic transplantation but also for cell therapies in regenerative medicine for patients with acute myocardial infarction, spinal cord injury, and stroke, among others. This paper reviews the regulation mechanisms underlying the homing and mobilization of BM hematopoietic stem/progenitor cells, investigating the following issues: (a) the role of different factors, such as stromal cell derived factor-1 (SDF-1), granulocyte colony-stimulating factor (G-CSF), and vascular cell adhesion molecule-1 (VCAM-1), among other ligands; (b) the stem cell count in peripheral blood and BM and influential factors; (c) the therapeutic utilization of this phenomenon in lesions in different tissues, examining the agents involved in HSPCs mobilization, such as the different forms of G-CSF, plerixafor, and natalizumab; and (d) the effects of this mobilization on BM-derived stem/progenitor cells in clinical trials of patients with different diseases.

• Publication year

  2013

• Venue

  BioMed Research International

• Publication date

  2013-06-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1155/2013/312656PMID 23844360PMCID 3703413
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Structure and functions of plasminogen/plasmin system].

  2014cited by this paper
• Advances in stem cell mobilization.

  2014cited by this paper
• Defining "poor mobilizer" in pediatric patients who need an autologous peripheral blood progenitor cell transplantation.

  2013cited by this paper
• Plerixafor plus granulocyte colony-stimulating factor improves the mobilization of hematopoietic stem cells in patients with non-Hodgkin lymphoma and low circulating peripheral blood CD34+ cells.

  2013cited by this paper
• Bioactive Lipids and Cationic Antimicrobial Peptides as New Potential Regulators for Trafficking of Bone Marrow-Derived Stem Cells in Patients with Acute Myocardial Infarction

  2013cited by this paper
• Chemokines and adult bone marrow stem cells.

  2012cited by this paper
• Predictive factors for inadequate stem cell mobilization in Chinese patients with NHL and HL: 14‐year experience of a single‐center study

  2012cited by this paper
• Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators

  2012cited by this paper
• The Plasminogen System in Regulating Stem Cell Mobilization

  2012cited by this paper
• Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization

  2012cited by this paper
• Antiapoptotic effects of Phe140Asn, a novel human granulocyte colony-stimulating factor mutant in H9c2 rat cardiomyocytes

  2012cited by this paper
• The SDF-1/CXCR4 axis in stem cell preconditioning.

  2012cited by this paper
• A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients

  2012cited by this paper
• Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA

  2012cited by this paper
• A risk-based approach to optimize autologous hematopoietic stem cell (HSC) collection with the use of plerixafor

  2012cited by this paper
• Advances in stem cell mobilization.

  2012cited by this paper
• Genetically manipulated progenitor/stem cells restore function to the infarcted heart via the SDF-1α/CXCR4 signaling pathway.

  2012cited by this paper
• Hematopoietic stem cell mobilization for gene therapy of adult patients with severe β-thalassemia: results of clinical trials using G-CSF or plerixafor in splenectomized and nonsplenectomized subjects.

  2012cited by this paper
• c-Kit-Mediated Functional Positioning of Stem Cells to Their Niches Is Essential for Maintenance and Regeneration of Adult Hematopoiesis

  2011cited by this paper
• Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data

  2011cited by this paper
• How I treat patients who mobilize hematopoietic stem cells poorly.

  2011influential reference
• Pathways implicated in stem cell migration: the SDF-1/CXCR4 axis.

  2011cited by this paper
• Proposed definition of ‘poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo

  2011cited by this paper
• CONDITIONING FOR HEMATOPOIETIC TRANSPLANTATION ACTIVATES THE COMPLEMENT CASCADE AND INDUCES A PROTEOLYTIC ENVIRONMENT IN BONE MARROW – A NOVEL ROLE FOR BIOACTIVE LIPIDS AND SOLUBLE C5b-C9 AS HOMING FACTORS

  2011cited by this paper
• The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells

  2011cited by this paper
• Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction

  2011cited by this paper
• Changes of cytokine levels during granulocyte–colony‐stimulating factor stem cell mobilization in healthy donors: association with mobilization efficiency and potential predictive significance

  2011cited by this paper
• Novel strategies for blood stem cell mobilization: special focus on plerixafor

  2011cited by this paper
• [Effect of combined therapy of granulocyte colony stimulating factor and bone marrow mesenchymal stem cells carrying hepatocyte growth factor gene on angiogenesis of myocardial infarction in rats].

  2011cited by this paper
• [Effect of erythropoietin combined with granulocyte-colony stimulating factor in the treatment of acute myocardial infarction in rats].

  2011cited by this paper
• The EBMT activity survey 2009: trends over the past 5 years

  2011cited by this paper
• Diabetes Impairs Hematopoietic Stem Cell Mobilization by Altering Niche Function

  2011cited by this paper
• Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization

  2011cited by this paper
• SDF-1α as a therapeutic stem cell homing factor in myocardial infarction.

  2011cited by this paper
• Is prolonged stem cell mobilization detrimental for hematopoiesis?

  2011cited by this paper
• In and out of the niche: perspectives in mobilization of hematopoietic stem cells.

  2011influential reference
• Targeting stem cell niches and trafficking for cardiovascular therapy.

  2011cited by this paper
• Troubleshooting: Quantification of mobilization of progenitor cell subsets from bone marrow in vivo.

  2010cited by this paper
• Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization

  2010influential reference
• BKT140 Is a Novel CXCR4 Antagonist with Stem Cell Mobilization and Antimyeloma Effects: An Open-Label First Human Trial In Patients with Multiple Myeloma Undergoing Stem Cell Mobilization for Autologous Transplantation

  2010cited by this paper
• Low-dose versus moderate-dose atorvastatin after acute myocardial infarction: 8-month effects on coronary flow reserve and angiogenic cell mobilisation

  2010cited by this paper
• Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma

  2010cited by this paper
• Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation.

  2010cited by this paper
• Granulocyte colony‐stimulating factor (G‐CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy

  2010cited by this paper
• First Results of a Phase-II Study with the New CXCR4 Antagonist POL6326 to Mobilize Hematopoietic Stem Cells (HSC) In Multiple Myeloma (MM)

  2010cited by this paper
• The role of chemokine receptor CXCR4 in lung cancer

  2010cited by this paper
• Plerixafor: A chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin's lymphoma or multiple myeloma.

  2010cited by this paper
• PLASMA SPHINGOSINE 1-PHOSPHATE IS A MAJOR CHEMOATTRACTANT THAT DIRECTS EGRESS OF HEMATOPOIETIC STEM PROGENITOR CELLS FROM BONE MARROW AND ITS LEVEL IN PERIPHERAL BLOOD INCREASES DURING MOBILIZATION DUE TO ACTIVATION OF COMPLEMENT CASCADE/MEMBRANE ATTACK COMPLEX

  2010cited by this paper
• Plerixafor Enables Successful Hematopoietic Stem Cell Collection in an Extensively Pretreated Patient with Testicular Cancer

  2010cited by this paper
• Adipose tissue is an extramedullary reservoir for functional hematopoietic stem and progenitor cells.

  2010cited by this paper
• Predicting Peripheral Blood Stem Cell Harvest Failure Using Circulating CD34 Levels: Developing Target-Based Cut-Points for Early Intervention

  2010cited by this paper
• Mobilization strategies in hard‐to‐mobilize patients with lymphoid malignancies

  2010cited by this paper
• Plerixafor: A Peripheral Blood Stem Cell Mobilizer

  2010cited by this paper
• Trends of hematopoietic stem cell transplantation in the third millennium

  2009cited by this paper
• Novel Trafficking Routes for Hematopoietic Stem and Progenitor Cells

  2009cited by this paper
• Poor hematopoietic stem cell mobilizers: A single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma

  2009cited by this paper
• Treatment with plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient.

  2009cited by this paper
• Successful stem cell remobilization using plerixafor (mozobil) plus granulocyte colony-stimulating factor in patients with non-hodgkin lymphoma: results from the plerixafor NHL phase 3 study rescue protocol.

  2009cited by this paper
• Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.

  2009cited by this paper
• Improving stem cell mobilization strategies: future directions

  2009cited by this paper
• IMPAIRED MOBILIZATION OF HEMATOPOITEIC STEM/PROGENITOR CELLS IN C5-DEFCIENT MICE SUPPORTS THE PIVOTAL INVOLVEMENT OF INNATE IMMUNITY IN THIS PROCESS AND REVEALS NOVEL PROMOBILIZATION EFFECTS OF GRANULOCYTES

  2009cited by this paper
• AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data

  2008cited by this paper
• The Role of CXCR7/RDC1 as a Chemokine Receptor for CXCL12/SDF-1 in Prostate Cancer*

  2008cited by this paper
• Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis

  2008cited by this paper
• A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma.

  2008cited by this paper
• The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans.

  2008cited by this paper
• Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab.

  2008cited by this paper
• Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.

  2008cited by this paper
• Haematopoietic stem cell release is regulated by circadian oscillations

  2008cited by this paper
• Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients

  2008cited by this paper
• Diprotin A Infusion into Nonobese Diabetic/Severe Combined Immunodeficiency Mice Markedly Enhances Engraftment of Human Mobilized CD34+ Peripheral Blood Cells

  2007cited by this paper
• Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells.

  2007cited by this paper
• Inhibition of CD26 in Human Cord Blood CD34+ Cells Enhances Their Engraftment of Nonobese Diabetic/Severe Combined Immunodeficiency Mice

  2007cited by this paper
• Hematopoietic progenitor cells (HPC) from mobilized peripheral blood display enhanced migration and marrow homing compared to steady-state bone marrow HPC.

  2007cited by this paper
• Granulocyte Colony-Stimulating Factor and Granulocyte Macrophage Colony-Stimulating Factor Exacerbate Atherosclerosis in Apolipoprotein E–Deficient Mice

  2007cited by this paper
• Preserve mesenchymal stem cell research.

  2007cited by this paper
• AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent.

  2007cited by this paper
• Mechanisms of hematopoietic stem cell mobilization: when innate immunity assails the cells that make blood and bone.

  2006cited by this paper
• Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization

  2006cited by this paper
• Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches.

  2006cited by this paper
• Cyclophosphamide mobilization does not improve outcome in patients receiving stem cell transplantation for multiple myeloma.

  2006cited by this paper
• Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice.

  2006cited by this paper
• Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.

  2006cited by this paper
• Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony‐stimulating factor (G‐CSF): impact of age, sex, donor weight and type of G‐CSF used

  2006cited by this paper
• Sphingosine-1-Phosphate Stimulates the Functional Capacity of Progenitor Cells by Activation of the CXCR4-Dependent Signaling Pathway via the S1P3 Receptor

  2006cited by this paper
• Prospective randomized comparative observation of single- vs split-dose lenograstim to mobilize peripheral blood progenitor cells following chemotherapy in patients with multiple myeloma or non-Hodgkin’s lymphoma

  2005cited by this paper
• The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor.

  2005cited by this paper
• Superior mobilisation of haematopoietic progenitor cells with glycosylated G‐CSF in male but not female unrelated stem cell donors

  2005cited by this paper
• Structure and function of the plasminogen/plasmin system

  2005cited by this paper
• Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte–colony‐stimulating factor by single‐dose administration of AMD3100, a CXCR4 antagonist

  2005cited by this paper
• The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.

  2005cited by this paper
• VCAM-1 expression in adult hematopoietic and nonhematopoietic cells is controlled by tissue-inductive signals and reflects their developmental origin.

  2005cited by this paper
• Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003

  2005cited by this paper
• The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes*

  2005cited by this paper
• How do stem cells find their way home?

  2005cited by this paper
• G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes

  2005cited by this paper
• Factors associated with granulocyte colony‐stimulating factor‐induced peripheral blood stem cell yield in healthy donors

  2005cited by this paper
• Mobilization of peripheral blood stem cells in CLL patients after front-line fludarabine treatment

  2005cited by this paper
• The bone marrow vascular niche: home of HSC differentiation and mobilization.

  2005cited by this paper
• Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

  2005cited by this paper

• Twice or once a day? Filgrastim dosing schedule for peripheral hematopoietic stem cells mobilization

  2025cites this paper
• Treatment of Corticosteroid-Induced Myopathy through Filgrastim Induced Endogenous Stem Cells Mobilization in Male Albino Rats

  2025cites this paper
• CCL28: A Promising Biomarker for Assessing Salivary Gland Functionality and Maintaining Healthy Oral Environments

  2024cites this paper
• Long Non-Coding RNA-Cardiac-Inducing RNA 6 Mediates Repair of Infarcted Hearts by Inducing Mesenchymal Stem Cell Differentiation into Cardiogenic Cells through Cyclin-Dependent Kinase 1

  2024cites this paper
• Correlation between SDF-1α, CD34 positive hematopoietic stem cells and CXCR4 expression with liver fibrosis in CCl4 rat model

  2023cites this paper
• Update on the Clinical Applications of Mesenchymal Stem Cells

  2023cites this paper
• Nanocarrier Based Targeting of Vascular Cell Adhesion Molecule-1 for Diagnosis and Treatment of Atherosclerosis: Current Status and Future Perspectives

  2023cites this paper
• Endothelial progenitor cells in the host defense response.

  2022cites this paper
• Tumor-specific imaging probes in preclinical applications and clinical trials

  2022cites this paper
• Encouraging effect of autologous bone marrow aspirate concentrate in rehabilitation of children with cerebral palsy.

  2022cites this paper
• Stem cell secreted factor therapy regenerates the ovarian niche and rescues follicles.

  2021cites this paper
• Safety and Efficacy of Autologous Non-Hematopoietic Enriched Stem Cell Nebulization in Covid-19 Patients. A Randomized Clinical Trial, Abu Dhabi 2020.

  2021cites this paper
• Enforced sialyl‐Lewis‐X (sLeX) display in E‐selectin ligands by exofucosylation is dispensable for CD19‐CAR T‐cell activity and bone marrow homing

  2021cites this paper
• Safety and efficacy of autologous non-hematopoietic enriched stem cell nebulization in COVID-19 patients: a randomized clinical trial, Abu Dhabi 2020

  2021cites this paper
• The Rising Role of Mesenchymal Stem Cells in the Treatment of Various Infectious Complications

  2020cites this paper
• Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications

  2020cites this paper
• The effect of serum vitamin B12, folate, ferritin levels and transferrin saturation on stem cell mobilization in allogeneic donors.

  2020cites this paper
• Acute Exercise in Hypobaric Hypoxia Attenuates Endothelial Shedding in Subjects Unacclimatized to High Altitudes

  2020cites this paper
• Introductory Chapter: Update on Mesenchymal and Induced Pluripotent Stem Cells

  2020cites this paper
• Inferior prognosis in poor mobilizing myeloma patients.

  2020cites this paper
• Donor CSF3R with the rs3917980A/G or G/G genotype is correlated with better leukemia-free survival after allogenic hematopoietic stem cell transplantation

  2020cites this paper
• Adhesion Deregulation in Acute Myeloid Leukaemia

  2019cites this paper
• A computational model of feedback-mediated hematopoietic stem cell differentiation in vitro

  2019cites this paper
• Engineering a multicellular vascular niche to model hematopoietic cell trafficking

  2018cites this paper
• An open-label proof-of-concept study of intrathecal autologous bone marrow mononuclear cell transplantation in intellectual disability

  2018cites this paper
• Stem Cell Drugs - A New Generation of Biopharmaceuticals

  2018cites this paper
• Evolution of Stem Cell Products in Medicine: Future of Off-the-Shelf Products

  2018cites this paper
• Improving the characterization of endothelial progenitor cell subsets by an optimized FACS protocol

  2017cites this paper
• Cure of Insulin-Dependent Diabetes Mellitusby an Autologous Hematopoietic StemCell Transplantation Performed to ControlMultiple Myeloma in a Patient with ChronicRenal Failure on Regular Hemodialysis

  2017cites this paper
• KAB Study among Voluntary Blood Donors Regarding their Awareness and Willingness to Join Stem Cell Registry and to Donate Hematopoietic Stem Cells

  2017cites this paper
• Comparative analysis of curative effect of bone marrow mesenchymal stem cell and bone marrow mononuclear cell transplantation for spastic cerebral palsy

  2017cites this paper
• Clinical neurorestorative progresses in cerebral palsy

  2017cites this paper
• Vascular precursor cells in tissue injury repair.

  2017cites this paper
• Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial

  2017cites this paper
• Mobilization and Homing of Bone Marrow Stem Cells After Stroke

  2017cites this paper
• Endothelial progenitor cells for cellular angiogenesis and repair: lessons learned from experimental animal models.

  2017cites this paper
• Modified Hydrogels to Enhance Cellular Therapy for AKI: A Translational Challenge.

  2016cites this paper
• Acute myeloid leukemia in the vascular niche.

  2016cites this paper
• Migration of bone marrow progenitor cells in the adult brain of rats and rabbits.

  2016cites this paper
• Significant Improvement in Ejection Fraction and Functional Class after Two Years of Cells Transplantation

  2016cites this paper
• Research progress of SDF-1/CXCR-4 pathway in mesenchymal stem cell homing after myocardial infarction

  2016cites this paper
• CXCL12/SDF-1 and Hematopoiesis

  2016cites this paper
• Interaktion von Tumorzellen in der hämatopoetischen Stammzellnische

  2016cites this paper
• Daily propranolol prevents prolonged mobilization of hematopoietic progenitor cells in a rat model of lung contusion, hemorrhagic shock, and chronic stress.

  2015cites this paper
• The interplay between biomaterial degradation and tissue properties : relevance for in situ cardiovascular tissue engineering

  2015cites this paper
• Myokardiale Regeneration im Glukagon-like-peptide-1 Rezeptor knock out Mausmodell

  2015cites this paper
• Vascular cell adhesion molecule‐1 (VCAM‐1)—An increasing insight into its role in tumorigenicity and metastasis

  2015cites this paper
• A Clinical Study of Autologous Bone Marrow Mononuclear Cells for Cerebral Palsy Patients: A New Frontier

  2015cites this paper
• Stromal derived factor‐1 and granulocyte‐colony stimulating factor treatment improves regeneration of Pax7−/− mice skeletal muscles

  2015cites this paper
• Granulocyte Colony-Stimulating Factor Induces Osteoblast Inhibition by B Lymphocytes and Osteoclast Activation by T Lymphocytes during Hematopoietic Stem/Progenitor Cell Mobilization.

  2015cites this paper
• Aging Effects on Cardiac Progenitor Cell Physiology.

  2015cites this paper
• Hematopoietic progenitor cell mobilization for autologous transplantation – a literature review

  2015cites this paper
• Computer tools and collaborative translational research in the life sciences: the further advance of genomics and proteomics

  2015cites this paper
• Découverte de nouveaux marqueurs pharmacogénomiques de la maladie du greffon contre l'hôte en transplantation de cellules souches hématopoïétiques

  2014cites this paper
• Stem Cell Therapy for Cerebral Palsy – A Novel Option

  2014cites this paper
• Angiotensin-(1-7) reverses angiogenic dysfunction in corpus cavernosum by acting on the microvasculature and bone marrow-derived cells in diabetes.

  2014cites this paper
• Bioactive Lipids and Cationic Antimicrobial Peptides as New Potential Regulators for Trafficking of Bone Marrow-Derived Stem Cells in Patients with Acute Myocardial Infarction

  2013cites this paper
• The emerging use of bone marrow-derived mesenchymal stem cells in the treatment of human chronic wounds

  2013cites this paper
• Cardiomyopathy and Cell Therapy: Ejection Fraction Improvement and Cardiac Muscle Mass Increasing, after a Year of Bone Marrow Stem Cells Transplantation, by Magnetic Resonance Image

  2013cites this paper
• Annals of Rehabilitation Medicine Effect of Intravenous Infusion of G-csf-mobilized Peripheral Blood Mononuclear Cells on Upper Extremity Function in Cerebral Palsy Children

  year unknowncites this paper
• STEM CELL HOMING AS A PROMISING STRATEGY FOR BONE REGENERATION: FOCUS ON BIOMATERIALS

  year unknowncites this paper